KPF
ABUS icon

K2 Principal Fund’s Arbutus Biopharma ABUS Stock Holding History

K2 Principal Fund’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,884
Closed -$112K – 284
2018
Q3 		$112K Sell
11,884
-8,707
-42% -$86.5K 0.01% 307
2018
Q2 		$150K Sell
20,591
-130,487
-86% -$777K 0.01% 287
2018
Q1 		$755K Sell
151,078
-110,248
-42% -$584K 0.04% 243
2017
Q4 		$1.32M Buy
261,326
+11,311
+5% +$66.3K 0.1% 180
2017
Q3 		$1.55M Sell
250,015
-125,839
-33% -$538K 0.1% 171
2017
Q2 		$1.35M Sell
375,854
-52,113
-12% -$179K 0.09% 180
2017
Q1 		$1.39M Sell
427,967
-15,920
-4% -$44.2K 0.12% 163
2016
Q4 		$1.09M Buy
443,887
+336,267
+312% +$978K 0.1% 153
2016
Q3 		$370K Buy
107,620
+44,070
+69% +$172K 0.04% 215
2016
Q2 		$221K Buy
63,550
+33,796
+114% +$143K 0.03% 215
2016
Q1 		$123K Buy
+29,754
New +$106K 0.02% 202
2015
Q4 		– Sell
-37,135
Closed -$226K – 201
2015
Q3 		$226K Sell
37,135
-5,500
-13% -$48.8K 0.04% 133
2015
Q2 		$506K Buy
+42,635
New +$649K 0.09% 126
2015
Q1 		– Sell
-12,735
Closed -$261K – 156
2014
Q4 		$193K Buy
+12,735
New +$220K 0.05% 143

Other funds holding ABUS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

K2 Principal Fund's ABUS Position: Q4 2018 in Review

K2 Principal Fund sold out of Arbutus Biopharma (ABUS) in Q4 2018, closing a stake of 11,884 shares — an estimated $112K sold.

K2 Principal Fund first reported a position in ABUS in Q4 2014 and held it in 14 quarters. The position peaked at $1.55M in Q3 2017. 71 funds tracked by Wall St. Rank hold ABUS as of Q4 2018.

  • K2 Principal Fund reported no remaining Arbutus Biopharma position as of Q4 2018 after selling out during the quarter.
  • K2 Principal Fund sold 11,884 Arbutus Biopharma shares in Q4 2018, an estimated $112K.
  • K2 Principal Fund first reported a position in Arbutus Biopharma in Q4 2014 and held it in 14 quarters.
  • K2 Principal Fund's Arbutus Biopharma position peaked at $1.55M in Q3 2017.
  • 71 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2018.

Based on K2 Principal Fund's 13F filing for Q4 2018, filed 13 Feb 2019.